LRI Investments LLC Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

LRI Investments LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,379 shares of the medical equipment provider’s stock after buying an additional 70 shares during the quarter. LRI Investments LLC’s holdings in Intuitive Surgical were worth $742,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in ISRG. Dynamic Advisor Solutions LLC increased its holdings in Intuitive Surgical by 2.5% in the 2nd quarter. Dynamic Advisor Solutions LLC now owns 10,245 shares of the medical equipment provider’s stock valued at $4,557,000 after purchasing an additional 252 shares during the last quarter. LVW Advisors LLC lifted its stake in Intuitive Surgical by 9.9% during the 2nd quarter. LVW Advisors LLC now owns 1,320 shares of the medical equipment provider’s stock worth $587,000 after acquiring an additional 119 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in Intuitive Surgical by 6.0% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 7,310 shares of the medical equipment provider’s stock valued at $3,252,000 after acquiring an additional 417 shares in the last quarter. Cooper Financial Group increased its stake in Intuitive Surgical by 9.2% during the second quarter. Cooper Financial Group now owns 629 shares of the medical equipment provider’s stock worth $280,000 after purchasing an additional 53 shares during the period. Finally, M&G Plc boosted its stake in shares of Intuitive Surgical by 53.5% in the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock valued at $2,256,000 after purchasing an additional 1,766 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Stifel Nicolaus upped their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Leerink Partners boosted their price objective on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $541.33.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. This represents a 35.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,723 shares of company stock worth $26,241,747 over the last three months. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 0.5 %

ISRG stock opened at $550.41 on Monday. The firm has a 50 day moving average of $516.21 and a 200-day moving average of $474.66. The company has a market cap of $196.05 billion, a price-to-earnings ratio of 88.49, a PEG ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a 12-month low of $307.72 and a 12-month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.